Globavir Exclusively Licenses Oncology Program to Sorrento Therapeutics
Globavir Biosciences, Inc., a specialty biotechnology company developing small molecule drugs to treat cancer and infectious diseases, and Sorrento Therapeutics, Inc., an... Read More